Principal Investigator
Eugene Schiff
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20231333
Clinical Trial Summary
A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Fazirsiran in the Treatment of Alpha-1 Antitrypsin DeficiencyAssociated Liver Disease With METAVIR Stage F1 Fibrosis
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu